Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Qin Song

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Zhonghua Yi Xue Za Zhi|October 31, 2013
[Primary testicular non-Hodgkin's lymphoma: clinical analysis of 21 cases]Chen Zhang, Xiao-pei Wang, Zhi-tao Ying, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 27, 2013
[Purging with rituximab in vivo combined with autologous peripheral blood stem cell transplantation for aggressive B-cell lymphoma: clinical analysis of 26 cases]Chen Zhang, Xiao-pei Wang, Zhi-tao Ying, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|November 2, 2011
[Plasma levels of VEGF-C, VEGF-D, VEGFR-2 and VEGFR-3 in patients with newly diagnosed lymphomas]Fang Liu, Yu-Qin Song, Chen Zhang, et al.
Zhonghua Yi Xue Za Zhi|January 19, 2013
[Safety and adverse event profiling of pegylated L-asparaginase combined chemotherapy in the treatment of lymphoma]Ling-yan Ping, Wen Zheng, Xiao-pei Wang, et al.
Zhonghua Yi Xue Za Zhi|September 15, 2011
[Central nervous system lymphoma and its significance]Wen Zheng, Ning-jing Lin, Yan Xie, et al.
Acta Pharmacologica Sinica|November 6, 2020
Population pharmacokinetics of the anti-PD-1 antibody camrelizumab in patients with multiple tumor types and model-informed dosing strategyChen-Yu Wang, Chang-Cheng Sheng, Guang-Li Ma, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 17, 2012
[An analysis of hepatitis B virus infection rate in 405 cases of non-Hodgkin lymphoma]Wei-Ping Liu, Wen Zheng, Xiao-Pei Wang, et al.
Chinese Journal of Cancer|June 19, 2012
The clinical features, therapeutic responses, and prognosis of the patients with mantle cell lymphomaZhi-Tao Ying, Wen Zheng, Xiao-Pei Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 7, 2013
[Prognostic value of (18)F-FDG PET/CT after first-line treatment in patients with diffuse large B cell lymphoma]Zhi-tao Ying, Xue-juan Wang, Yu-qin Song, et al.
Future Oncology (London, England)|November 29, 2023
Tislelizumab and radiation therapy in low-risk early-stage extranodal natural killer/T-cell lymphoma, nasal type: a phase II study protocolJia-Ying Li, Shu-Nan Qi, Chen Hu, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Zhonghua Yi Xue Za Zhi|October 31, 2013
[Primary testicular non-Hodgkin's lymphoma: clinical analysis of 21 cases]Chen Zhang, Xiao-pei Wang, Zhi-tao Ying, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 27, 2013
[Purging with rituximab in vivo combined with autologous peripheral blood stem cell transplantation for aggressive B-cell lymphoma: clinical analysis of 26 cases]Chen Zhang, Xiao-pei Wang, Zhi-tao Ying, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|November 2, 2011
[Plasma levels of VEGF-C, VEGF-D, VEGFR-2 and VEGFR-3 in patients with newly diagnosed lymphomas]Fang Liu, Yu-Qin Song, Chen Zhang, et al.
Zhonghua Yi Xue Za Zhi|January 19, 2013
[Safety and adverse event profiling of pegylated L-asparaginase combined chemotherapy in the treatment of lymphoma]Ling-yan Ping, Wen Zheng, Xiao-pei Wang, et al.
Zhonghua Yi Xue Za Zhi|September 15, 2011
[Central nervous system lymphoma and its significance]Wen Zheng, Ning-jing Lin, Yan Xie, et al.
Acta Pharmacologica Sinica|November 6, 2020
Population pharmacokinetics of the anti-PD-1 antibody camrelizumab in patients with multiple tumor types and model-informed dosing strategyChen-Yu Wang, Chang-Cheng Sheng, Guang-Li Ma, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 17, 2012
[An analysis of hepatitis B virus infection rate in 405 cases of non-Hodgkin lymphoma]Wei-Ping Liu, Wen Zheng, Xiao-Pei Wang, et al.
Chinese Journal of Cancer|June 19, 2012
The clinical features, therapeutic responses, and prognosis of the patients with mantle cell lymphomaZhi-Tao Ying, Wen Zheng, Xiao-Pei Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 7, 2013
[Prognostic value of (18)F-FDG PET/CT after first-line treatment in patients with diffuse large B cell lymphoma]Zhi-tao Ying, Xue-juan Wang, Yu-qin Song, et al.
Future Oncology (London, England)|November 29, 2023
Tislelizumab and radiation therapy in low-risk early-stage extranodal natural killer/T-cell lymphoma, nasal type: a phase II study protocolJia-Ying Li, Shu-Nan Qi, Chen Hu, et al.
Pageof 6